BCP
ELV icon

BSN Capital Partners’s Elevance Health ELV Stock Holding History

BSN Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-219,603
Closed -$80.4M – 10
2024
Q4 		$80.4M Buy
+219,603
New +$91.9M 3.21% 7

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BSN Capital Partners's ELV Position: Q1 2025 in Review

BSN Capital Partners sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 219,603 shares — an estimated $80.4M sold.

BSN Capital Partners first reported a position in ELV in Q4 2024 and held it in 1 quarter. The position peaked at $80.4M in Q4 2024. 1,661 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • BSN Capital Partners reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • BSN Capital Partners sold 219,603 Elevance Health shares in Q1 2025, an estimated $80.4M.
  • BSN Capital Partners first reported a position in Elevance Health in Q4 2024 and held it in 1 quarter.
  • BSN Capital Partners's Elevance Health position peaked at $80.4M in Q4 2024.
  • 1,661 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on BSN Capital Partners's 13F filing for Q1 2025, filed 14 May 2025.